GlassScriptPhysician profile
Mary Baylon
NPI 1679993372
$2,949.35
in general payments reported to CMS, 2019-2025
34 companies · $411 in 2025
The $411 reported for 2025 was more than what 76% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $459 · 2020: $400 · 2021: $304 · 2022: $752 · 2023: $431 · 2024: $192 · 2025: $411.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,034.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,033.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $309.74 | 2019-2022 | |
| Pfizer INC. | $285.01 | 2019-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $272.60 | 2019-2025 | |
| Sage Therapeutics, LLC | $206.43 | 2023-2025 | Zurzuvae |
| Exeltis, USA INC. | $186.23 | 2020-2025 | Slynd |
| Aspira Women'S Health INC | $157.90 | 2022-2023 | Ova1 |
| Terumo Medical Corporation | $143.11 | 2022 | |
| Astellas Pharma US INC | $140.28 | 2019-2025 | Myrbetriq, Veozah |
| Shield Therapeutics INC | $129.38 | 2023-2025 | Accrufer |
| Channel Medsystems, INC. | $104.18 | 2022-2024 | |
| Myovant Sciences INC. | $103.89 | 2021-2022 | |
| Mylan Pharmaceuticals INC. | $98.94 | 2021-2022 | |
| Coopersurgical, INC. | $62.80 | 2020-2024 | Paragard T 380a, Mara Console |
| Organon LLC | $60.34 | 2023-2025 | Jada System, Nexplanon |
| Hologic Sales and Service, LLC | $57.07 | 2019-2025 | Fluent Fluid Management System, Myosure Tissue Removal Device, Novasure |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Duchesnay USA Incorporated | $53.51 | 2019 | |
| Daiichi Sankyo INC. | $52.93 | 2019-2022 | |
| Medtronic, INC. | $50.19 | 2022 | |
| Amag Pharmaceuticals, INC. | $49.01 | 2019 | |
| Agile Therapeutics, INC. | $47.79 | 2021-2022 | |
| Avion Pharmaceuticals | $46.30 | 2019-2022 | |
| Roche Diagnostics Corporation | $38.54 | 2019 | |
| Therapeuticsmd, INC. | $38.49 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $36.20 | 2019-2020 | |
| Supernus Pharmaceuticals, INC. | $34.61 | 2025 | Qelbree |
| Sumitomo Pharma America, INC. | $33.19 | 2023-2024 | Myfembree |
| Gynesonics, INC. | $26.07 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Allergan, INC. | $23.37 | 2020 | |
| Octapharma USA, INC. | $22.67 | 2025 | Fibryga |
| Meditrina | $17.63 | 2023-2025 | |
| Exact Sciences Corporation | $16.29 | 2025 | The Cologuard Plus Collection Kit |
| Lupin INC. | $15.63 | 2019 | |
| Olympus America INC. | $14.78 | 2019 | |
| Ethicon US, LLC | $14.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Baylon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.